• SHARE

There’s a new king in the domestic drug industry after hopes for a coronavirus treatment helped turbocharge its shares.

Chugai Pharmaceutical Co., the nation’s leading oncology company, is the best performer on the Nikkei 225 this year, up almost 60 percent versus the 2.4 percent drop in the broader index. The surge has brought its market value neck-and-neck with that of electronics giant Sony Corp. to make it the seventh-largest company in the country.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)